---
title: "Keen Vision Acquisition - Unit | 10-Q: FY2025 Q3 Revenue: USD 0"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/265583820.md"
datetime: "2025-11-12T21:03:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/265583820.md)
  - [en](https://longbridge.com/en/news/265583820.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/265583820.md)
generator: "portal-rs"
---

# Keen Vision Acquisition - Unit | 10-Q: FY2025 Q3 Revenue: USD 0

Revenue: As of FY2025 Q3, the actual value is USD 0.

EBIT: As of FY2025 Q3, the actual value is USD -248.48 K.

### Segment Revenue

-   The company has not commenced any operations and will not generate operating revenues until after the completion of a Business Combination.

### Operational Metrics

-   Net income for the nine months ended September 30, 2025, was $1,499,692, compared to $6,600,651 for the same period in 2024.
-   Net income for the three months ended September 30, 2025, was $373,466, compared to $1,559,923 for the same period in 2024.

### Cash Flow

-   Net cash used in operating activities for the nine months ended September 30, 2025, was - $664,463, compared to - $681,249 for the same period in 2024.
-   Net cash provided by investing activities for the nine months ended September 30, 2025, was $16,457,732.
-   Net cash used in financing activities for the nine months ended September 30, 2025, was - $15,831,937.

### Unique Metrics

-   Dividend income earned in investments held in Trust Account for the nine months ended September 30, 2025, was $2,111,544, compared to $5,596,106 for the same period in 2024.

### Future Outlook and Strategy

-   The company has entered into a merger agreement with Medera Inc., a clinical stage biopharmaceutical company, with the intention to effectuate a business combination.
-   The company has extended the time to complete its business combination until November 27, 2025, with the possibility of further extensions.
-   The company faces substantial doubt about its ability to continue as a going concern if a Business Combination is not consummated by November 27, 2025.

### Related Stocks

- [KVACU.US](https://longbridge.com/en/quote/KVACU.US.md)
- [KVAUF.US](https://longbridge.com/en/quote/KVAUF.US.md)

## Related News & Research

- [INFINITT Healthcare's (KOSDAQ:071200) Shareholders Have More To Worry About Than Lackluster Earnings](https://longbridge.com/en/news/306338723.md)
- [Anthropic PBC (ANT) Claims Claude Solved The 167 Year Old Riemann Hypothesis](https://longbridge.com/en/news/306374461.md)
- [Is it time to buy at the bottom? Jensen Huang is still being smeared. Anthropic's IPO = a horror story.](https://longbridge.com/en/news/306347695.md)
- [Anthropic CEO vacations at Italian resort after public listing](https://longbridge.com/en/news/306344644.md)
- [Claude helped Anthropic's Levent Alpöge crack the Riemann hypothesis, he claims](https://longbridge.com/en/news/306339966.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**